Toward the evaluation of function in genetic variability: Characterizing human SNP frequencies and establishing BAC‐transgenic mice carrying the humanCYP1A1_CYP1A2locus
- 10 January 2005
- journal article
- research article
- Published by Hindawi Limited in Human Mutation
- Vol. 25 (2), 196-206
- https://doi.org/10.1002/humu.20134
Abstract
Interindividual differences in human CYP1A1 and CYP1A2 expression appear to be associated with variability in risk toward various types of environmental toxicity and cancer. These two genes are oriented head‐to‐head on human chromosome 15; the 23.3‐kb spacer region might contain distinct regulatory regions for CYP1A1 and distinct regulatory regions for CYP1A2, or the regulatory regions for the two genes might overlap one another. From 24 unrelated subjects of five major, geographically‐isolated subgroups, we resequenced both genes (all exons and all introns) plus some 3′ flanking sequences and the entire spacer region (39.6 kb total); 85 SNPs were found, 49 of which were not currently in the National Center for Biotechnology Information (NCBI) database. Of the 57 double‐hit SNPs, we carried out SNP‐typing in 94 Africans, 96 Asians, and 83 Caucasians and found striking ethnic differences in SNP frequencies and haplotype evolution; the two CYP1A1 SNPs and the one CYP1A2 SNP that are most commonly used in epidemiological studies were shown not to be representative haplotype tag SNPs across these three human subgroups. Four BAC‐transgenic mouse lines, carrying the human CYP1A2 and 15,190 bp of 5′ flank, expressed only negligible basal or inducible CYP1A2 mRNA. A fifth BAC‐transgenic mouse line, carrying both the human CYP1A1 and CYP1A2 genes and ample amounts of 3′ flanking sequences, plus all of the spacer region––in the absence of the mouse Cyp1a1 or Cyp1a2 genes––expressed the human CYP1A1 and CYP1A2 mRNA, protein and enzyme activities in liver and nonhepatic tissues very similar to that of the mouse. Comparison of this hCYP1A1_1A2 transgenic line with hCYP1A1_1A2 lines carrying other common human haplotypes will enable us to evaluate function in human CYP1A1_CYP1A2 locus variability, with regard to toxicity and cancer caused by combustion products. Hum Mutat 25:196–206, 2005.Funding Information
- National Institutes of Health (P30 ES06096, R01 ES0621, R01 ES08147)
This publication has 50 references indexed in Scilit:
- A novel induction mechanism of the rat CYP1A2 gene mediated by Ah receptor–Arnt heterodimerBiochemical and Biophysical Research Communications, 2004
- The Human CYP1A1 Gene Is Regulated in a Developmental and Tissue-specific Fashion in Transgenic MiceJournal of Biological Chemistry, 2004
- Evolutionary Discrimination of Mammalian Conserved Non-Genic Sequences (CNGs)Science, 2003
- Features of Evolution and Expansion of Modern Humans, Inferred from Genomewide Microsatellite MarkersAmerican Journal of Human Genetics, 2003
- CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancerInternational Journal of Cancer, 2003
- Proposal for an allele nomenclature system based on the evolutionary divergence of haplotypesHuman Mutation, 2002
- SPECTROPHOTOMETRIC ASSAY FOR ACETANILIDE 4-HYDROXYLASE, AN ESTIMATE OF CYP1A2 ENZYME ACTIVITYToxicology Mechanisms and Methods, 2001
- P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclaturePharmacogenetics, 1996
- The Aryl Hydrocarbon Receptor ComplexAnnual Review of Pharmacology and Toxicology, 1995
- Linkage disequilibrium in finite populationsTheoretical and Applied Genetics, 1968